Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control studySalim Yusuf, Sonia S. Anand, Steven Hawken et al.|The Lancet|2005Cited by 2.9k
The Clinical Significance of Interleukin-6 in Heart Failure: Results from the BIOSTAT-CHF StudyGeorge Markousis‐Mavrogenis, Peter van der Meer, Jasper Tromp et al.|European Journal of Heart Failure|2019Cited by 281
Development and Validation of Multivariable Models to Predict Mortality and Hospitalization in Patients with Heart FailureAdriaan A. Voors, Aeilko H. Zwinderman, Wouter Ouwerkerk et al.|European Journal of Heart Failure|2017Cited by 266
A Systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: Rationale, Design, and Baseline Characteristics of BIOSTAT-CHFAdriaan A. Voors, Marco Metra, Stefan D. Anker et al.|European Journal of Heart Failure|2016Cited by 204
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fractionKoen W. Streng, Adriaan A. Voors, Jan F. Nauta et al.|International Journal of Cardiology|2018Cited by 204